ASPREE PUBLICATIONS

THE ASPREE PROTOCOL

A study protocol is the ‘bible’ for a clinical trial which must be approved by a Human Research Ethics Committee (HRECs) before a study can legally commence in Australia. The ASPREE Study Protocol documents the background to the study, the trial design, objectives, hypothesis, endpoints, patient well-being, study visit measurements, analysis and adherence to ethical regulatory and administrative considerations.

• ASPREE Protocol AUS Version # 9 Nov 2014
• ASPREE-XT Protocol AUS Version # 4 Jan 2020

DOWNLOADABLE ASPREE BROCHURES

• The ASPREE Information brochure for general information about the aspirin trial (concluded)
• The ASPREE-XT information brochure for general information about the follow-up observational study in ASPREE participants (current)

EDITIONS OF THE ASPREE & ASPREE-XT PARTICIPANT NEWSLETTERS ‘ABOUT A TABLET’

This biannual publication helps keep participants and the general community up to date on all things ASPREE – from study progress through to news stories, reminders and snippets. All submissions and suggestions are welcome! Send through your suggestions to aspree@monash.edu

• Winter_Participant_Newsletter 2020
• Summer_Participant_Newsletter 2019-2020
• Summer_AutumnParticipant_Newsletter 2018-2019
• Summer_Participant_Newsletter 2017-2018
• Winter_SpringParticipant_Newsletter 2017
• Winter_SpringParticipant_Newsletter 2016
• SummerParticipant_Newsletter 2015-2016
• Autumn_WinterParticipant_Newsletter 2015
• Spring_Participant_Newsletter 2014 and a letter of thanks from Prof john McNeil
• Spring_SummerParticipant_Newsletter 2013-2014
• Autumn_WinterParticipant_Newsletter 2013
• Spring_SummerParticipant_Newsletter 2012-2013
• Autumn_WinterParticipant_Newsletter 2012
• Spring_SummerParticipant_Newsletter 2011-2012
• WinterParticipant_Newsletter 2011
• Spring_SummerParticipant_Newsletter 2010-2011
• July_Participant_Newsletter 2010
• April_Participant_Newsletter 2010